ALLR ▼ -0.9% - Allarity Therapeutics, Inc. $ALLR - Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development Allarity Therapeutics fell 0.9% today despite receiving a Japanese patent grant for its stenoparib DRP® companion diagnostic, a development that expands the company's intellectual property protection for its lead oncology candidate in a major market. The patent reinforces Allarity's ability to commercialize stenoparib alongside its associated diagnostic tool, though the market response remained modest. 15-SEP-2026 08:00 AM ET